Clinical Trial Update: A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update reports completion of a study evaluating HRS-9813 capsules and tablets in healthy subjects, with pulmonary fibrosis referenced in the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• HRS-9813 Capsule (HRS-9813)
• HRS-9813 Tablet (HRS-9813)

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Pulmonary Fibrosis | Phase 1 | Status: COMPLETED